Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Lemarquis, A; Campbell, T; Aranda-Guillén, M; Hennings, V; Brodin, P; Kämpe, O; Blennow, K; ... Ekwall, O; + view all (2021) Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis. Journal of Allergy and Clinical Immunology 10.1016/j.jaci.2021.03.034. (In press). Green open access

Preview

Text
main (8).pdf - Published Version
Download (952kB) | Preview

Type:	Article
Title:	Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
Location:	United States
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1016/j.jaci.2021.03.034
Publisher version:	https://doi.org/10.1016/j.jaci.2021.03.034
Language:	English
Additional information:	This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI:	https://discovery.ucl.ac.uk/id/eprint/10127251

Downloads since deposit

49Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item